Abnormal papanicolaou smears, genital tract infections, and contraception

Health Care for Woman International

Volumn 20, Issue 1, 1999, Pages 17-27

  Hawkins, Joellen W ^a,b,d   Matteson, Peggy S ^c,d   Mersha, Gloria ^e  

^a BOSTON COLLEGE   (United States)

^b Crittenton Hastings House   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d Codman Square Health Center ^*  (United States)

^e Lynn Community Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; FEMALE; GYNECOLOGIC DISEASE; HUMAN; INCIDENCE; INFECTION; METHODOLOGY; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTRACEPTION; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INCIDENCE; INFECTION; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032600299     PISSN: 07399332     EISSN: None     Source Type: Journal    
DOI: 10.1080/073993399245935     Document Type: Article

References (33)

1. Becker, T. M., Wheeler, C. M., McGough, N. S., Parmenter, C. A., Jordan, S. W., Stidley, C. A., McPherson, R. S., & Dorin, M. H. (1994). Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. Journal of the American Medical Association, 271, 1181-1188.
2. Benrubi, G. I. (1991). Vaginitis and female cancer. In B. J. Horowitz & P. Mardh (Eds.), Vaginitis and vaginosis (pp. 145-148). New York: Wiley-Liss.
3. Bosch, F. X., Munoz, N., de Sanjose, S. (1997). Human papillomavirus and other risk factors for cervical cancer. Biomedicine and Pharmacotherapy, 51, 268-275.
4. Carson, S. (1997), Human papillomatous virus infection update: Impact on women's health. Nurse Practitioner, 22(4), 24-37.
5. Celentano, D. D., Klassen, A. C., Weisman, C. S., & Rosenshein, N. B. (1987). The role of contraceptive use in cervical cancer: The Maryland cervical cancer case control study. American Journal of Epidemiology, 126, 592-604.
6. Centers for Disease Control and Prevention. (1990). Risk for cervical disease in HIV-infected women: New York City. Morbidity & Mortality Weekly Report, 39, 846-849.
7. Centers for Disease Control and Prevention. (1998). 1998 sexually transmitted diseases treatment guidelines. Morbidity & Mortality Weekly Report, 47, 1-115.
8. Connelly, L. M., Keele, B. S., Kleinbeck, S. V., Schneider, J. K., & Cobb, A. K. (1993). A place to be yourself: Empowerment from the client's perspective. Image: Journal of Nursing Scholarship, 23, 297-303.
9. Contraceptions, STDs, and risk-taking behavior: Highlights from a recent ARHP conference. (1994). The Contraception Report, 5(3), 4-7.
10. Crowther, M. E. (1995). Is the nature of cervical carcinoma changing in young women? Obstetric and Gynecologic Survey, 50, 71-82.
11. Crum, C. P., & Roche, J. K. (1990). Papillomavirus-related genital neoplasia: Present and future prevention. Cancer Detection and Prevention, 14, 465-469.
12. Downey, G. P., Bavin, P. J., Deery, A. R. S., Crow, J., Griffiths, P. D., Emery, V. C., & Walker, P. G. (1994). Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet, 344, 432-435.
13. Ehrenreich, B., & English, D. (1973). Complaints and disorders: The sexual politics of sickness. Old Westbury, NY: Feminist Press.
14. Ferenczy, A., & Jenson, A. B. (1996). Tissue effects and host response: The key to the rational triage of cervical neoplasia. Obstetrics and Gynecology Clinics of North America, 23, 759-782.
15. Gitsch, G., Kainz, C., Studnicka, M., Reinthaller, A., Tatra, G., & Breitenecker, G. (1992). Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia. Archives of Gynecology and Obstetrics, 252, 25-30.
16. Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338, 423-428.
17. Larsen, N. S. (1994). Invasive cervical cancer rising in young white females. Journal of the National Cancer Institute, 86, 6-7.
18. Lavin, C., Goodman, E., Perlman, S., Kelly, L. S., & Emans, S. J. (1997). Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic. Journal of Pediatric Adolescent Gynecology, 10, 141-145.
19. Leonardo, C., & Chrisler, J. C. (1992). Women and sexually transmitted diseases. Women & Health, 18(4), 1-15.
20. Lungu, O., Sun, X. W., Felix, J., Richart, R. M., Silverstein, S., & Wright, T. C. (1992). Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. Journal of the American Medical Association, 267, 2493-2496.
21. Matteson, P. S. & Hawkins, J. W. (1997). Women's patterns of contraceptive use. Health Care for Women International, 18 (5), 455-466.
22. Munoz, N., & Bosch, F. X. (1996). The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bulletin of the Pan American Health Organization, 30, 362-377.
23. Niruthisard, S., Roddy, R. E., & Chutivongse, S. (1992). Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet, 339, 1371-1374.
24. O'Connell, M. L. (1996). The effect of birth control methods on sexually transmitted disease/HIV risk. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 25, 416-480.
25. Parkin, D. M., Pisani, P., & Ferlay, J. (1993). Estimates of the world-wide incidence of eighteen major cancers in 1985. International Journal of Cancer, 54, 594-606.
26. Redfern, N., & Hutchinson, S. (1994). Women's experiences of repetitively contracting sexually transmitted diseases. Health Care for Women International, 15, 423-433.
27. Roe, V. A. & Gudi, A. (1997). Pharmacologic management of sexually transmitted diseases. Journal of Nurse-Midwifery, 42, 275-289.
28. Shew, M. L., Fortenberry, J. D., Miles, P., & Amortegui, A. J. (1994). Interval between menarche and first sexual intercourse, related risk of human papillomavirus infection. Journal of Pediatrics, 125, 661-666.
29. Stone, K. M., Zaidi, A., Rosero-Bixby, L., Oberle, M. W., Larsen, S., Reynolds, G., Nahmias, A. J., Lee, F. K., Schachter, J., & Guinan, M. E. (1995). Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology, 6, 409-414.
30. Trubo, R. (1994). The battle against cervical cancer. Organon's Magazine on Women and Health, 4, 22-25.
31. Wittkowski, K. M., Susser, E., & Dietz, K. (1998). The protective effect of condoms and nonozynol-9 against HIV infection. American Journal of Public Health, 88, 590-596.
32. Wright, T. C., Ellerbrock, T. V., Chiasson, M. A., Van Devanter, N., Sun, X. W., & The New York Cervical Disease Study. (1994). Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. Obstetrics & Gynecology, 84, 591-597.
33. Yoder, L., & Rubin, M. (1992). The epidemiology of cervical cancer and its precursors. Oncology Nursing Forum, 19, 485-493.